Navigation Links
Ganeden Biotech Granted 100th Probiotic Patent
Date:10/14/2010

CLEVELAND, Oct. 14 /PRNewswire/ -- Ganeden Biotech, Inc., maker of the patented probiotic strain GanedenBC30®, recently announced the granting of the company's 100th patent, which expands the use and scope of the GanedenBC30® probiotic to help prevent lactic-acid bacteria and to better improve digestive and immune health.  

The 100th patent comes in the wake of Ganeden's latest collaboration with Organic Milling marking a milestone for the company as it continues to develop new product partnerships with some of the world's most innovative food and product manufacturers.  

From Bigelow® Tea and Red Mango to Guernsey Farms Dairy and Agostoni Chocolate, Ganeden's range of products and partnerships is a testament to the versatility and durability of their probiotic strain Bacillus coagulans GBI-30, 6086 branded as GanedenBC30®, which has the unique ability to survive the harsh manufacturing process and still be activated in the body.  This is attributed to the naturally occurring layer of organic material that protects the genetic core of the bacteria throughout the manufacturing and digestion process.

"The 100th patent approval is a true accomplishment for us, as it reflects the extent of our innovation and collaboration since the GanedenBC30® probiotic was first developed and patented just a little over a decade ago," said Sean Farmer, Chief Scientific Officer and co-founder of Ganeden Biotech. Farmer is credited with discovering the GanedenBC30® probiotic and has written each subsequent patent since helping co-found the company in 1997.  "We owe our success to our unrivaled dedication to creativity and perseverance, inherent within each of our partnerships, which have enabled us to provide proven health benefits to millions of consumers via a variety of functional health products."

About Ganeden Biotech

Founded in 1997, Ganeden Biotech, Inc. is based in Cleveland, Ohio, and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage® and Sustenex® brands. It also licenses its patented probiotic bacteria, GanedenBC30®, for use in commercial food and beverage applications, nutraceuticals and in animal health industries. GanedenBC30® is self-affirmed GRAS (Generally Recognized as Safe) by an independent panel of experts assembled to assess its safety in use as a food ingredient. For more information about licensing opportunities visit ganedenlabs.com and for probiotic supplement information visit digestiveadvantage.com or sustenex.com.


'/>"/>
SOURCE Ganeden Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Introduces the First Probiotic Thin Strip
2. Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock
3. Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology
4. Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
5. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
6. Genesis Biopharma to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13
7. Reportlinker Adds the Top 10 Biotechnology Companies: Positioning, Performance and SWOT Analyses
8. Trius to Participate in Antibiotics Panel Discussion at Citis 5th Annual Biotech Day
9. Maven Biotechnologies Receives $1.96 Million From the National Institutes of Health (NIH) to Develop Their LFIRE™ Label-Free Detection Technology for Proteomics
10. Biotech Posts Strong Third Quarter Performance as Capital Markets Go on a Tear
11. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... - FACIT announced a seed stage investment in ... created by FACIT focused on developing a portfolio ... non-dilutive capital, achieves a targeted $3.0M financing for ... to accelerate the nomination of a candidate drug ... a strategic partnership for clinical trials in patients ...
(Date:3/22/2017)... March 22, 2017   VWR ... of product and service solutions to laboratory ... has acquired EPL Archives, Inc., an international ... the entire regulated product research, development and ... storage and ancillary services. EPL Archives is ...
(Date:3/22/2017)... (PRWEB) , ... March 21, 2017 , ... Okyanos Cell ... seminar as part of their live events series, “Stem Cell Therapy: The Next Phase ... facility under the 2013 Stem Cell Research and Therapy Act, Okyanos maintains ...
(Date:3/22/2017)... ... , ... Benchworks CEO Thad L. Bench Sr. will participate in ... in San Diego. The event is a gathering of executive leadership from companies in ... Christian Meyer will also participate in the forum. Participants will discuss the future of ...
Breaking Biology Technology:
(Date:2/24/2017)... Feb. 24, 2017  EyeLock LLC, a leader of iris-based ... iris biometric solution on the latest Qualcomm® Snapdragon™ ... Mobile World Congress 2017 (February 27 – ... Hall 3, Stand 3E10. The ... security platform—a combination of hardware, software and ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):